Clearside Biomedical, Inc. — Director's Dealing 2024

Apr 16, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Clearside Biomedical, Inc. (CLSD)
CIK: 0001539029
Period of Report: 2024-04-15

Reporting Person: Gibney Anthony S (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-04-15	Stock Option (right to buy)	$1.29	A	45000	Acquired	2034-04-15	Common Stock (45000)	Direct

Footnotes

F1: The shares underlying such option will vest in 36 equal monthly installments on the last day of each month commencing on April 30, 2024, subject to the Reporting Person's continuous service through each vesting date.